Interns occasionally pause in the middle of the hallway to gaze at the quantum systems cooling inside sealed chambers in a room on the fourth floor of IBM’s Thomas J. Watson Research Center in Yorktown Heights, New York. It resembles a chandelier created by a science fiction enthusiast rather than a computer. However, that image—strange, otherworldly, and unbelievably costly—is gradually giving way to something more commonplace and, for investors who are paying close attention, more intriguing. The era of quantum computing is coming to an end. slowly. unevenly. However, it is departing.
Industry insiders characterize a series of events over the last eighteen months as an inflection point, though that term runs the risk of becoming as overused as “paradigm shift” once was. But something does seem to be shifting. After years of circling the idea of commercialization, companies are now quietly winning government contracts, going public, and producing real hardware. Significant capital is beginning to follow because the narratives have changed enough.
Even though the majority of ordinary investors are unaware of it, Infleqtion is one of the names worth keeping an eye on. The business was given a spot on NASA’s Quantum Gravity Gradiometer Pathfinder mission, which will launch in 2030 and be the first quantum sensor to measure Earth’s gravitational field from orbit. That is a delivery schedule with a client, not marketing jargon for a future innovation.
A few days prior to that announcement, Infleqtion also disclosed a $6.2 million contract with the Department of Energy’s ARPA-E division, which focuses on using quantum computing to help optimize electrical grids. As AI and electrification push power infrastructure to its limits, conventional software is finding it more and more difficult to solve this problem. The announcement of the NASA deal caused a 15% increase in Churchill Capital Corp X, the SPAC merging with Infleqtion. Since then, insiders have sold millions of shares, which raises concerns, but the underlying contract work feels more like proof of concept than theater.
A Canadian company and Nvidia partner, Xanadu Quantum Technologies, approached markets in a different way. Through a SPAC merger, it made its Nasdaq debut in late March, rising 15% on its first day before plummeting in after-hours trading. The volatility of the stock reveals everything about the current state of the market’s emotions, from being eager enough to buy on day one to being anxious enough to sell by dusk. Around the same time, Singapore-based Horizon Quantum went public; since then, it has lost about 18% of its value. Although these figures aren’t encouraging, they also don’t necessarily rule someone out. Prior to their success, early biotechs frequently appeared awful on paper.
This industry is now receiving significant funding from the US government. Recently, the Commerce Department signed letters of intent to invest approximately $2 billion in nine American quantum companies. The funding was initially allocated by the CHIPS Act and was converted into non-voting equity stakes by the current administration. IBM, the safer, more reputable wager, is at one end of the spectrum; it will receive $1 billion from the government and match it with another billion of its own. On the other end of the spectrum are D-Wave Quantum, Rigetti Computing, and Infleqtion, which are smaller, more erratic, and generate little income but are now supported by what one analyst referred to as a government “backstop.” That language is difficult to ignore. The incentive structure is somewhat altered because these are equity positions rather than grants.
These pure-play quantum names are similar to early-stage biotech, according to Andrew Rocco, a tech analyst at Zacks Investment Research: they are high risk, have asymmetric upside, and are not yet based on traditional fundamentals. It’s a helpful framing. Perhaps the geopolitical aspect is what sets it apart from biotech. Quantum capability is being viewed by governments in the United States, China, South Korea, and the United Kingdom as a national security asset rather than just a business opportunity. In order to get important economic sectors ready for commercial adoption, the United Kingdom has established a Quantum Growth Alliance. At the moment, China is the world leader in quantum computing patent applications. The race is no longer hypothetical.
The moment quantum machines surpass classical supercomputers on practical problems, or practical quantum advantage, is still a few years away. Most analysts predict early demonstrations in 2028 or 2029 and commercially significant applications in the mid-2030s. However, the window for investments seldom waits for certainty. The stocks with the best underlying physics might not be the ones making significant movements over the next two years. They will be the ones whose names are so obscure that the crowd hasn’t yet arrived, whose government contracts have already been signed, and whose hardware is actually shipping.
